Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2023-04-11 00:00:00 ET · period of report 2023-04-10 · accession 0001104659-23-044168 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-11 | 2023-04-10 | PTGX | SELICK HAROLD E | Dir | M - OptEx | $0.87 | +6,196 | 21.5K | +40% | +$5,391 |
| D | 2023-04-11 | 2023-04-10 | PTGX | SELICK HAROLD E | Dir | M - OptEx | $0.00 | -6,196 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-10 | M | A | 6,196 | $0.87 | 21,506 | D | — | — | (F1) The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date. |
| 2 | Derivative | Stock Option (right to buy) | 2023-04-10 | M | D | 6,196 | $0.00 | 0 | D | $0.87 · — to 2023-09-26 | 6,196 Common Stock | (F2) The stock option is vested in full. |